Therefore, direct target of estrogen signaling pathway and estrogen receptors, such as selective estrogen receptor modulators and aromatase enzyme, has been used as a therapeutic approach for patients by inhibiting tumor growth [68]. Here, ESR1 is linked to neoplasm.